Fig. 5. Rises in RSV PRNT during the surveillance period.

Slides:

Advertisements

Similar presentations

First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip by Robert Farra, Norman F. Sheppard, Laura McCabe, Robert M. Neer, James M. Anderson,

Advertisements

Fig. 1. TP is highly expressed in myeloma.

Fig. 8. Recurrent copy number amplification of BRD4 gene was observed across common cancers. Recurrent copy number amplification of BRD4 gene was observed.

Fig. 7. Intrapatient variation in key contact signatures for PGDM1400 and PGT121. Intrapatient variation in key contact signatures for PGDM1400 and PGT121.

Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.

Fig. 1. Generation of ERY974. Generation of ERY974. (A) Schematic illustration of ERY974 structure and the introduced mutations. The two Fab arms share.

Fig. 5. Protective efficacy of the combination of PGT121 + PGDM1400 against a mixed SHIV challenge in rhesus monkeys. Protective efficacy of the combination.

Fig. 2 LYM attractor metagene.

Fig. 3. Structure of ALS-associated RNA binding proteins.

Fig. 4 Bacterial taxonomic groups that discriminate among RYGB-, SHAM-, and WMS-derived samples. Bacterial taxonomic groups that discriminate among RYGB-,

Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.

Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

Fig. 4. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive and HBeAg-negative chimpanzees. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive.

In vivo prophylactic and therapeutic efficacy of C12G6 in mice

Fig. 2. Engraftment of CART-EGFRvIII and cytokine modulation in the peripheral blood. Engraftment of CART-EGFRvIII and cytokine modulation in the peripheral.

Fig. 4. Functional annotation of VUS in EGFR.

Fig. 3. Frequencies of amino acids at critical PGT121 and contact sites in the SHIV-SF162P3 challenge stock. Frequencies of amino acids at critical.

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Fig. 2. Response to repeat dosing of chimpanzees with ARC-520.

Fig. 2. GPC3 expression in normal and tumor tissues.

Fig. 5. Immunohistochemistry of the tumor microenvironment in GBM specimens before and after CART-EGFRvIII infusion. Immunohistochemistry of the tumor.

Expression of CD36 and psap in a TMA of human ovarian cancer patients

Increased ADMA in pregnancy is associated with SGA birth outcomes

Fig. 6. Effects of CD31-NP targeting in perfused human kidneys.

Fig. 4. Specific versus nonspecific NP accumulation.

Fig. 4. In vivo analysis of slpA mutant in the Syrian Golden hamster.

Fig. 1. IS mediates a hyperthrombotic uremic phenotype in an AHR-dependent manner across CKD stages. IS mediates a hyperthrombotic uremic phenotype in.

Expression of THBS2 in human PanIN tissue and PDAC tumor tissue

Fig. 4. MATE1 transcription in RCC.

Fig. 2. Best model fits. Best model fits. Illustration of the best model fits for the (A) basic, (B) continuous, and (C) cluster models. See Table 1 and.

Fig. 4 Nanocages captured multiple TB-related analytes.

Fig. 4 Phylogeny of rabies strains isolated during and after the mass vaccination campaign. Phylogeny of rabies strains isolated during and after the mass.

Fig. 5. MMP-7 expression in human liver, EHBD, and gallbladder.

Fig. 1. Experimental workflow of the dAST method and computationally estimated operational space. Experimental workflow of the dAST method and computationally.

Persistence of CAR4 cells is reduced after sustained TCR engagement

Fig. 7 BRD0705 impairs colony formation in AML cell lines and patient cells and shows in vivo efficacy in multiple AML mouse models. BRD0705 impairs colony.

Fig. 7 Human study design for device testing.

Fig. 7. NPs accumulate at sites of vascular obstruction.

Fig. 1. Map showing the study catchment area in the East of England.

Fig. 7. Inhibitory mechanisms of C12G6.

Fig. 5 Local gel scaffold for T cell memory response.

Fig. 3. H3N2 incidence forecasts based on the cluster model for the Unites States. H3N2 incidence forecasts based on the cluster model for the Unites States.

Fig. 1. In vitro binding and neutralization activities of C12G6.

Fig. 7 CSPG4-high GBMs show more microglia than CSPG4-low GBMs and express TNFα. CSPG4-high GBMs show more microglia than CSPG4-low GBMs and express TNFα.

Comparison of therapeutic efficacies of C12G6 and other bnAbs in mice

Fig. 2 Analysis of CLL lymph nodes.

Fig. 2. IONP characterization.

Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.

Fig. 2. Exposure of both TCR and CAR antigens diminishes efficacy of CAR8 but not CAR4 cells. Exposure of both TCR and CAR antigens diminishes efficacy.

Fig. 6. CXM correlates with age and growth velocity.

Fig F-FGln shows uptake in human gliomas undergoing progression.

Fig. 5. Prophylactic and therapeutic efficacy of C12G6 in ferrets.

Fig. 3 CSF1 is expressed in human melanoma.

Fig. 7 Analysis of the bacterial nidus within tissue abscesses by MALDI IMS demonstrates a paucity of calprotectin signal. Analysis of the bacterial nidus.

Fig. 7 Vaccine-induced influenza-specific B cells are not maintained in peripheral blood. Vaccine-induced influenza-specific B cells are not maintained.

Fig. 1 Anti-LtxA antibody concentrations in various patient groups.

Vaccination induces activation of cTFH cells and transient ASCs

Fig. 5 Early and modest immune response at day 3 after exposure in Delayed animals. Early and modest immune response at day 3 after exposure in Delayed.

Fig. 4 cTFH1 cells correlate with a boosting of influenza-specific memory B cells. cTFH1 cells correlate with a boosting of influenza-specific memory B.

Fig. 5 Wireless, full-body pressure mapping on a human subject in a hospital bed. Wireless, full-body pressure mapping on a human subject in a hospital.

Fig. 7 Correlation of NHP and human ISGs.

Supplementary Figure e-3

Fig. 2. Bacterial/viral score in COCONUT-conormalized whole-blood validation data sets. Bacterial/viral score in COCONUT-conormalized whole-blood validation.

Fig. 5. Vitamin B12 supplementation in the host altered the transcriptome of P. acnes in the skin microbiota. Vitamin B12 supplementation in the host altered.

Fig. 1. Detection of circulating tumor DNA in CRPC patients.

Fig. 5. Octet BLI competition assay using D25 and motavizumab.

Fig. 3 Plumage brightness (PC1) for each sex in relation to morphological, ecological, and behavioral traits. Plumage brightness (PC1) for each sex in.

Fig. 5 Clustering of the distal gut microbiome, the C

Fig. 3. Association between peak CTL019 expansion and response.

Presentation transcript:

Fig. 5. Rises in RSV PRNT during the surveillance period. Rises in RSV PRNT during the surveillance period. RSV PRNT in sera from six vaccinees and three placebo recipients in whom ≥4-fold rises in titer between the pre- and postsurveillance specimens were detected (see text for additional details). Blue solid lines, vaccinees with rises in RSV PRNT in whom no RSV MAARI was detected (n = 5; corresponding to subjects 33, 35, 44, 46, and 56 in the supplementary tables); blue dashed line, vaccinee with rise in RSV PRNT in whom RSV MAARI was detected (n = 1; subject 38 in the supplementary tables); red solid line, placebo recipient with rise in RSV PRNT in whom no RSV MAARI was detected (n = 1; subject 36 in the supplementary tables); red dashed lines, placebo recipients with rise in RSV PRNT in whom RSV MAARI was detected (n = 2; subjects 43 and 57 in the supplementary tables). Antibody titers are expressed as 1/log2, but for ease of interpretation, titers corresponding to the arithmetic values of 1:16, 1:64, 1:256, 1:1024, and 1:4096 are also shown. Ruth A. Karron et al., Sci Transl Med 2015;7:312ra175 Published by AAAS